Clinical Trials Browser

OTHER × Lymphoma × Daclizumab × Clear all

NCT00002681 2011-06-10

Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma

Hodgkin Disease, Leukemia, Lymphoma, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative